# A Prospective, Non-interventional Study of JAKAVI® (Ruxolitinib) Treatment in Patients With Polycythemia Vera

> **NCT05853445** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 467 (actual)

## Conditions studied

- Polycythemia Vera

## Interventions

- **OTHER:** Jakavi

## Key facts

- **NCT ID:** NCT05853445
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-17
- **Primary completion:** 2023-05-03
- **Final completion:** 2023-05-03
- **Target enrollment:** 467 (ACTUAL)
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05853445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05853445, "A Prospective, Non-interventional Study of JAKAVI® (Ruxolitinib) Treatment in Patients With Polycythemia Vera". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05853445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*